JP

Jai Prakash Narula

Director Director DIN 06377339
DIN 06377339 First appointment Oct 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2012
Shareholding value Locked Premium profile

About Jai Prakash Narula

Data last updated:

Jai Prakash Narula has 14 years in corporate governance. Formerly with 1 company, such as Medicamen Biotech Limited. Engaged in Technology. Contributes to corporate operations.

DIN 06377339
Primary Designation Director
First Appointment 04 Oct 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Medicamen Biotech Limited L74899DL1993PLC056594
Whole-Time Director04 Oct 20121993Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medicamen Biotech Limited
Premium access

Shareholding and investment profile for Jai Prakash Narula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jai Prakash Narula

Jai Prakash Narula has 14 years in corporate governance. Formerly with 1 company, such as Medicamen Biotech Limited. Engaged in Technology. Contributes to corporate operations.

Jai Prakash Narula is associated with 0 companies as a director.

Jai Prakash Narula has expertise in Technology.

Jai Prakash Narula has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available